SCHEMBL1892422

SCHEMBL1892422

O=C(c1ccc(Br)cc1NS(=O)(=O)c1cccc2nccnc12)N1CCOc2cc(F)cc(F)c2C1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 20/20 0.69
CCKAR P32238 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1385983 0.92 CCKBR (0.70) CCKBR
SCHEMBL1886184 0.91 CCKBR (0.69) CCKBRCCKAR
SCHEMBL4693850 0.90 CCKBR (0.61) CCKBR
SCHEMBL1881790 0.89 CCKBR (0.70) CCKBRCCKAR
SCHEMBL1887198 0.86 CCKBR (0.75) CCKBR
SCHEMBL1381588 0.82 CCKBR (1.00) CCKBR
SCHEMBL1385770 0.81 CCKBR (0.70) CCKBR
SCHEMBL1891185 0.80 CCKBR (0.70) CCKBR
SCHEMBL1383041 0.79 CCKBR (1.00) CCKBR
SCHEMBL1382550 0.79 CCKBR (1.00) CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651621-B1 2- (QUINOXALIN-5-YLSULFONYLAMINO) -BENZAMIDE COMPOUNDS AS CCK2 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2008-08-06 EP claimed
US-7947833-B2 methods that are useful in the preparation of amidophenyl-sulfonylamino-quinoxaline compounds CCK2 modulators are disclosed by sulfonylation JANSSEN PHARMACEUTICA NV (BE) 2011-05-24 US disclosed
US-7288651-B2 Preparation of quinoxaline compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-30 US disclosed
US-7288651-B2 Preparation of quinoxaline compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-30 US disclosed